Results 181 to 190 of about 58,866 (354)
3. P values, power, and medical significance for credible results. [PDF]
Indrayan A.
europepmc +1 more source
Informed or misinformed consent and use of modified texture diets in dysphagia. [PDF]
O'Keeffe ST +9 more
europepmc +1 more source
We have established a humanized orthotopic patient‐derived xenograft (Hu‐oPDX) mouse model of high‐grade serous ovarian cancer (HGSOC) that recapitulates human tumor–immune interactions. Using combined anti‐PD‐L1/anti‐CD73 immunotherapy, we demonstrate the model's improved biological relevance and enhanced translational value for preclinical ...
Luka Tandaric +10 more
wiley +1 more source
Perceptions of fairness in gender relations: a qualitative study of South Korean middle-aged men. [PDF]
Lee Y, Park S, Kim J, Kim E.
europepmc +1 more source
Hippo pathway at the crossroads of stemness and therapeutic resistance in breast cancer
Dysregulation of the Hippo pathway drives nuclear accumulation of YAP/TAZ, activating stemness‐related transcriptional programs that sustain breast cancer stemness and fuel therapeutic resistance across subtypes, underscoring Hippo signaling as a targetable vulnerability. Figure created and edited with BioRender.com.
Giulia Schiavoni +11 more
wiley +1 more source
Plea Bargains as Drivers of Incarceration-Related Health Outcomes. [PDF]
Smith R.
europepmc +1 more source
The Internal Morality of Criminal Law. [PDF]
Edwards J, Yusari T.
europepmc +1 more source
Pancreatic sensory neurons innervating healthy and PDAC tissue were retrogradely labeled and profiled by single‐cell RNA sequencing. Tumor‐associated innervation showed a dominant neurofilament‐positive subtype, altered mitochondrial gene signatures, and reduced non‐peptidergic neurons.
Elena Genova +14 more
wiley +1 more source
Questioning our presumptions about the presumption of capacity. [PDF]
Astrachan IM, Ruck Keene A, Kim SYH.
europepmc +1 more source
KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan +16 more
wiley +1 more source

